Table 3.
Measurements | Group | P1 | |
---|---|---|---|
PrT | PRP | ||
VAS_0 | 129.37±20.00 (a) | 137.41±20.88 (a) | 0.177 |
VAS_21 days | 75.15±23.27 (b) | 86.45±27.97 (b) | 0.129 |
VAS_3 months | 51.41±28.33 (c) | 49.91±20.54 (c) | 0.837 |
VAS_6 months | 36.89±25.79 (d) | 33.27±15.56 (d) | 0.567 |
VAS_12 months | 29.89±25.86 (e) | 30.05±19.54 (d) | 0.981 |
P2 | <0.001 | <0.001 |
ANOVA was used for repeated measures. Means with the same letters (in the same column) are not statistically different, P1 – between-subject effect, P2 – within-subject effect. AOS scores of 2 groups significantly improved compared to pretreatment values, and there was no significant difference between the 2 groups at the follow-up periods.